content

Glenmark launches Tavulus for COPD treatment in Spain, becoming one of the first companies to launch a bioequivalent version of the dry powder inhaler

Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under...

Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups

Sweden and Denmark said they are pausing the use of Moderna's (MRNA.O) COVID-19 vaccine for younger age groups after reports of possible rare cardiovascular...

Moderna to Build State-of-the-Art mRNA Facility in Africa to Manufacture up to 500 Million Doses Per Year

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced it will build a state-of-the-art mRNA facility in Africa with the...

Etihad Cargo Expands its African Footprint with the Signing of Pharma Agreement with Astral Aviation and Kenya Airways

Etihad Cargo, the cargo and logistics arm of Abu Dhabiโ€™s Etihad Aviation Group, has expanded its pharma sector reach into Africa with the signing...

Pharmapack Report 2021: Digital data democratization, environmental factors & user experience driving device innovation in 2022

Pharmapack Report 2021 are released ahead of Pharmapack Europe, which will be held next week at Paris Expo, Porte de Versailles (October 13-14, 2021)....

Enzolytics and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies

Samsung Biologics , a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to...

New Elsevier report highlights progress towards disease-modifying treatments for pancreatitis

Elsevier, a global leader in research publishing and information analytics, has published the findings from a new report on emerging trends for pancreatitis in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read